| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/24/2011 | WO2011020133A1 Use of mimotopes of alpha-synuclein epitopes for treating lewy body diseases |
| 02/24/2011 | WO2011000945A3 Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns |
| 02/24/2011 | WO2010144059A3 Novel uses |
| 02/24/2011 | WO2010123999A3 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor |
| 02/24/2011 | WO2010115124A3 Compositions of cholinesterase inhibitors |
| 02/24/2011 | WO2010110923A3 Prophylactic and therapeutic treatment of alzheimer's disease |
| 02/24/2011 | WO2010108052A3 Amide derivatives as neuropeptide y5 receptor ligands |
| 02/24/2011 | WO2010087980A3 Bicyclic amide derivatives for the treatment of respiratory depression |
| 02/24/2011 | WO2010086860A3 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them |
| 02/24/2011 | WO2010009120A8 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents |
| 02/24/2011 | US20110047631 Heat shock protein deficiencies as model systems for brain pathology and cancer |
| 02/24/2011 | US20110046599 Multi-Day Delivery Of Biologically Active Substances |
| 02/24/2011 | US20110046546 Methods for treating headaches |
| 02/24/2011 | US20110046237 Compounds with activity at estrogen receptors |
| 02/24/2011 | US20110046235 Products comprising, and uses of, decarboxylated phenolic acids derived from chlorogenic acids of coffee |
| 02/24/2011 | US20110046232 Orally Dissolving Formulations of Memantine |
| 02/24/2011 | US20110046226 Pharmaceutical compositions for prevention of overdose or abuse |
| 02/24/2011 | US20110046223 Treatment of neurofibromatosis |
| 02/24/2011 | US20110046219 (het)aryl-p-quinone derivatives for treatment of mitochondrial diseases |
| 02/24/2011 | US20110046218 Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
| 02/24/2011 | US20110046213 Production of Delta 9 Tetrahydrocannabinol |
| 02/24/2011 | US20110046210 Substituted thiopenecarboxamides as ikk-beta serine-, threonine-protein kinase inhibitors |
| 02/24/2011 | US20110046185 Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof |
| 02/24/2011 | US20110046182 Efficient aspirin prodrugs |
| 02/24/2011 | US20110046180 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands |
| 02/24/2011 | US20110046179 Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 02/24/2011 | US20110046177 Therapeutic quinoline and naphthalene derivatives |
| 02/24/2011 | US20110046172 Medicinal Compositions |
| 02/24/2011 | US20110046171 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 02/24/2011 | US20110046170 Novel pyrimidine-pyridine derivatives |
| 02/24/2011 | US20110046166 Purine derivatives as a3 adenosine receptor-selective agonists |
| 02/24/2011 | US20110046160 Novel Class of Spiro Piperidines for the Treatment of Neurodegenerative Diseases |
| 02/24/2011 | US20110046156 Treatment of hearing and balance impairments with redox-active therapeutics |
| 02/24/2011 | US20110046155 Hydrobenzamide derivatives as inhibitors of hsp90 |
| 02/24/2011 | US20110046153 Medicaments |
| 02/24/2011 | US20110046151 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 02/24/2011 | US20110046149 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidine antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof |
| 02/24/2011 | US20110046145 Quinolizidinone M1 Receptor Positive Allosteric Modulators |
| 02/24/2011 | US20110046141 Use of pde5 inhibitors for treating circadian rhythm disorders |
| 02/24/2011 | US20110046139 Benzocycloheptane and benzoxepine derivatives |
| 02/24/2011 | US20110046138 Novel compounds advantageous in the treatment of central nervous system diseases and disorders |
| 02/24/2011 | US20110046137 Pyrazole Derivatives as P2X7 Modulators |
| 02/24/2011 | US20110046136 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associcated therewith |
| 02/24/2011 | US20110046131 Purines as pkc-theta inhibitors |
| 02/24/2011 | US20110046129 2-Phenylethylamino Derivatives as Calcium and/or Sodium Channel Modulators |
| 02/24/2011 | US20110046128 Novel compounds advantageous in the treatment of central nervous system diseases and disorders |
| 02/24/2011 | US20110046122 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines |
| 02/24/2011 | US20110046120 Treatment of impulse control disorders |
| 02/24/2011 | US20110046118 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
| 02/24/2011 | US20110046117 Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditions |
| 02/24/2011 | US20110046116 Sedative for use during eye surgery |
| 02/24/2011 | US20110046115 Mirtazapine Solid Dosage Forms |
| 02/24/2011 | US20110046114 Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046105 Heterocycle-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising them and use thereof |
| 02/24/2011 | US20110046103 Neurotherapeutic Cephalosporin Sulfoxide and Sulfone-Containing Compositions |
| 02/24/2011 | US20110046097 Substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 02/24/2011 | US20110046096 Novel piperazino-dihydrothienopyrimidine derivatives |
| 02/24/2011 | US20110046092 Small molecules for neuronal differentiation of embryonic stem cells |
| 02/24/2011 | US20110046090 Modulation of neurogenesis with gaba agents and gaba analogs |
| 02/24/2011 | US20110046087 Pharmaceutical composition, methods for treating and uses thereof |
| 02/24/2011 | US20110046081 Classical cannabinoid metabolites and methods of use thereof |
| 02/24/2011 | US20110046079 Use of Proton Pump Inhibitors as Drug Delivery Adjuvants |
| 02/24/2011 | US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 02/24/2011 | US20110046065 Low frequency glatiramer acetate therapy |
| 02/24/2011 | US20110046064 Methods and compositions using selective delta opioid receptor-1 agonists, delta opioid receptor-2 antagonists, and/or mu opioid receptor antagonists for treatment of substance-related disorders |
| 02/24/2011 | US20110045109 Novel nutraceutical compositions containing whole-fruit zanthoxylum bungeanum extract for cognition |
| 02/24/2011 | US20110045106 Coffee extract |
| 02/24/2011 | US20110045096 Solubilized delivery system for topical anesthetics |
| 02/24/2011 | US20110045090 Formulations of flibanserin |
| 02/24/2011 | US20110045074 Matrix type sustained-release preparation containing basic drug or salt thereof and, method for manufacturing the same |
| 02/24/2011 | US20110045059 Vaccine against varicella zoster virus |
| 02/24/2011 | US20110045014 Acceleration agent of calcium absorption |
| 02/24/2011 | US20110045007 Fusion or linked proteins with extended half life |
| 02/24/2011 | US20110045001 Transfection results of non-viral gene delivery systems by influencing of the innate immune system |
| 02/24/2011 | US20110045000 for inflammatory diseases such as rheumatoid arthritis; GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor); |
| 02/24/2011 | US20110044997 Methods |
| 02/24/2011 | US20110044996 Neutralizing antibodies |
| 02/24/2011 | US20110044988 Methods of treatment using anti-mif antibodies |
| 02/24/2011 | US20110044986 Anti-amyloid antibodies and uses thereof |
| 02/24/2011 | US20110044985 Antibodies directed against amyloid-beta peptide and methods using same |
| 02/24/2011 | US20110044974 Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy |
| 02/24/2011 | US20110044968 Compositions for treatment with metallopeptidases, methods of making and using the same |
| 02/24/2011 | US20110044955 Altering memory by affecting staufen |
| 02/24/2011 | US20110044946 Genetec regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
| 02/24/2011 | US20110044945 Agents for the treatment of multiple sclerosis and methods of using same |
| 02/24/2011 | US20110044944 Anti-inflammatory compositions for treating brain inflammation |
| 02/24/2011 | US20110044902 Modulation of the Immune Response |
| 02/24/2011 | US20110044901 Novel compounds |
| 02/24/2011 | US20110044898 Translocator protein ligands |
| 02/24/2011 | CA2771429A1 Use of mimotopes of alpha-synuclein epitopes for treating lewy body diseases |
| 02/24/2011 | CA2771228A1 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip |
| 02/24/2011 | CA2760802A1 Low frequency glatiramer acetate therapy |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287290A2 Nestin-expressing hair follicle stem cells |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2287191A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287190A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287163A1 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidine antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof |